CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides...
Brian McNamee
Non-Executive Independent Chairman of the Board
Paul Mckenzie
Chief Executive Officer, Managing Director, Executive Director
Joy Linton
Chief Financial Officer
William Mezzanotte M.D.
Executive Vice President, Head Research & Development and Chief Medical Officer
Mark Hill
Executive Vice President, Chief Digital Information Officer